J-Pharma

No open roles listed
Data updated Nov 20, 2026Full reportReport a mistake
Lately:3 news stories in 90 daysFollow changes →

Facts

as of Nov 20, 2026

細胞膜に存在するタンパク質で細胞内外への物質輸送を担う「SLCトランスポーター」を標的とした薬の開発を行っております。不治の病に希望をもたらす新医薬品の開発を目指します。.

Sources: company registers, GLEIF, Wikidata, the company's site, Alion job postingsReport a mistake

Products

Products →

J-Pharma has 2 clinical trials on record, 2 under way.

Clinical trials
A Study to Select a Dose Regimen (Part A) and to Investigate Overall Survival (Part B) With Nanvuranlat Compared With P…
phase 3 · under way · 480 participants · Advanced Biliary Tract Cancer; Biliary Tract Cancer (BTC)
May 2026
A Study of JPH034 in Healthy Adult Participants
phase 1 · under way · 40 participants · Health Adult Subjects
Mar 2026
Source: each app’s App Store and Google Play page (an app counts as the company’s when its developer site is on the company’s domain); the products its own site names.
Sources: the outlets named on each headline, each story once

What the registers and the postings say about this employer.

Sanctions lists
OFAC SDN, EU consolidated · sanctionssearch.ofac.treas.gov ↗
No match
Phishing reports
OpenPhish, Phishing.Database · openphish.com ↗
None
Layoff notices
US WARN notices on file · dol.gov ↗
None
Full employer checkScam signs in adverts, mail records, visa registers, domain history
Sources: company registers, the Alion truth index, OFAC and EU sanctions lists, US WARN notices